HK1243422A1 - 三草癌菌素dc-45-a2的全合成及三草癌菌素类似物的制备 - Google Patents
三草癌菌素dc-45-a2的全合成及三草癌菌素类似物的制备 Download PDFInfo
- Publication number
- HK1243422A1 HK1243422A1 HK18102899.8A HK18102899A HK1243422A1 HK 1243422 A1 HK1243422 A1 HK 1243422A1 HK 18102899 A HK18102899 A HK 18102899A HK 1243422 A1 HK1243422 A1 HK 1243422A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- trioxacarcin
- analogs
- preparation
- total synthesis
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462094662P | 2014-12-19 | 2014-12-19 | |
| US62/094,662 | 2014-12-19 | ||
| US201562186128P | 2015-06-29 | 2015-06-29 | |
| US62/186,128 | 2015-06-29 | ||
| PCT/US2015/066703 WO2016100833A2 (en) | 2014-12-19 | 2015-12-18 | Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1243422A1 true HK1243422A1 (zh) | 2018-07-13 |
Family
ID=56127867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18102899.8A HK1243422A1 (zh) | 2014-12-19 | 2015-12-18 | 三草癌菌素dc-45-a2的全合成及三草癌菌素类似物的制备 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US10899773B2 (enExample) |
| EP (1) | EP3233877A4 (enExample) |
| JP (1) | JP2017537968A (enExample) |
| KR (1) | KR20170122718A (enExample) |
| CN (1) | CN107250144A (enExample) |
| AU (1) | AU2015364347A1 (enExample) |
| BR (1) | BR112017013194A2 (enExample) |
| CA (1) | CA2970955A1 (enExample) |
| CL (1) | CL2017001599A1 (enExample) |
| CO (1) | CO2017007074A2 (enExample) |
| CR (1) | CR20170331A (enExample) |
| DO (1) | DOP2017000144A (enExample) |
| EA (1) | EA201791388A1 (enExample) |
| EC (1) | ECSP17046657A (enExample) |
| GT (1) | GT201700139A (enExample) |
| HK (1) | HK1243422A1 (enExample) |
| IL (1) | IL252947A0 (enExample) |
| MA (1) | MA41216A (enExample) |
| MX (1) | MX2017008162A (enExample) |
| PE (1) | PE20171787A1 (enExample) |
| PH (1) | PH12017501147A1 (enExample) |
| SG (1) | SG11201704935XA (enExample) |
| WO (1) | WO2016100833A2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210230178A1 (en) * | 2017-08-17 | 2021-07-29 | William Marsh Rice University | Trioxacarcin analogs and dimers as potent anticancer agents |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5815995A (ja) | 1981-07-22 | 1983-01-29 | Kyowa Hakko Kogyo Co Ltd | Ｄｃ−４５−ａ↓１およびｄｃ−４５−ａ↓２ならびにそれらの製造法 |
| EP0157203A3 (en) * | 1984-04-04 | 1986-10-01 | American Cyanamid Company | Antitumor agents ll-d49194 alpha 1, ll-d49194 beta, ll-d49194 beta 2, ll-d49194 upsilon, ll-d49194 delta, ll-d49194 epsilon, ll-d49194 zeta, and ll-d49194 eta |
| JPS63135389A (ja) * | 1986-11-26 | 1988-06-07 | Kyowa Hakko Kogyo Co Ltd | Ｄｃ−４５類の誘導体 |
| WO2011119549A1 (en) | 2010-03-22 | 2011-09-29 | President And Fellows Of Harvard College | Trioxacarcins and uses thereof |
| US9775915B2 (en) * | 2012-11-26 | 2017-10-03 | President And Fellows Of Harvard College | Trioxacarcins, trioxacarcin-antibody conjugates, and uses thereof |
-
2015
- 2015-12-17 MA MA041216A patent/MA41216A/fr unknown
- 2015-12-18 AU AU2015364347A patent/AU2015364347A1/en not_active Abandoned
- 2015-12-18 PE PE2017001101A patent/PE20171787A1/es unknown
- 2015-12-18 WO PCT/US2015/066703 patent/WO2016100833A2/en not_active Ceased
- 2015-12-18 BR BR112017013194-3A patent/BR112017013194A2/pt not_active Application Discontinuation
- 2015-12-18 CN CN201580076346.2A patent/CN107250144A/zh active Pending
- 2015-12-18 CA CA2970955A patent/CA2970955A1/en not_active Abandoned
- 2015-12-18 US US15/537,319 patent/US10899773B2/en active Active
- 2015-12-18 EP EP15871176.2A patent/EP3233877A4/en not_active Withdrawn
- 2015-12-18 CR CR20170331A patent/CR20170331A/es unknown
- 2015-12-18 KR KR1020177020092A patent/KR20170122718A/ko not_active Withdrawn
- 2015-12-18 EA EA201791388A patent/EA201791388A1/ru unknown
- 2015-12-18 SG SG11201704935XA patent/SG11201704935XA/en unknown
- 2015-12-18 HK HK18102899.8A patent/HK1243422A1/zh unknown
- 2015-12-18 MX MX2017008162A patent/MX2017008162A/es unknown
- 2015-12-18 JP JP2017532666A patent/JP2017537968A/ja not_active Withdrawn
-
2017
- 2017-06-15 IL IL252947A patent/IL252947A0/en unknown
- 2017-06-19 GT GT201700139A patent/GT201700139A/es unknown
- 2017-06-19 CL CL2017001599A patent/CL2017001599A1/es unknown
- 2017-06-19 PH PH12017501147A patent/PH12017501147A1/en unknown
- 2017-06-19 DO DO2017000144A patent/DOP2017000144A/es unknown
- 2017-07-14 CO CONC2017/0007074A patent/CO2017007074A2/es unknown
- 2017-07-19 EC ECIEPI201746657A patent/ECSP17046657A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112017013194A2 (pt) | 2018-01-02 |
| EA201791388A1 (ru) | 2017-11-30 |
| EP3233877A2 (en) | 2017-10-25 |
| EP3233877A4 (en) | 2018-10-17 |
| AU2015364347A1 (en) | 2017-07-13 |
| SG11201704935XA (en) | 2017-07-28 |
| CN107250144A (zh) | 2017-10-13 |
| WO2016100833A3 (en) | 2017-01-05 |
| CO2017007074A2 (es) | 2017-10-20 |
| GT201700139A (es) | 2018-10-24 |
| PH12017501147A1 (en) | 2018-03-05 |
| JP2017537968A (ja) | 2017-12-21 |
| US10899773B2 (en) | 2021-01-26 |
| PE20171787A1 (es) | 2017-12-28 |
| DOP2017000144A (es) | 2017-09-29 |
| ECSP17046657A (es) | 2019-03-29 |
| CL2017001599A1 (es) | 2018-11-09 |
| WO2016100833A2 (en) | 2016-06-23 |
| KR20170122718A (ko) | 2017-11-06 |
| MA41216A (fr) | 2017-10-24 |
| US20190023717A1 (en) | 2019-01-24 |
| MX2017008162A (es) | 2018-03-06 |
| CA2970955A1 (en) | 2016-06-23 |
| CR20170331A (es) | 2017-11-17 |
| IL252947A0 (en) | 2017-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019500599A1 (en) | Sweet flavor modifier | |
| JOP20170122B1 (ar) | معدِّل نكهة حلوة | |
| MX2016016143A (es) | Compuestos de [1,2,4]triazol sustituido. | |
| HK1245019A1 (zh) | 吡啶酰胺化合物作爲杀真菌剂的用途 | |
| EP3484504A4 (en) | COMPOUNDS, COMPOSITIONS AND METHODS OF TREATMENT OF DISEASE | |
| MX2016002544A (es) | Compuestos utiles como inmunomoduladores. | |
| MY177031A (en) | Tetrahydropyridopyrazines modulators of gpr6 | |
| WO2015195656A3 (en) | Synthesis of polycyclic-carbamoylpyridone compounds | |
| EP3204386A4 (en) | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | |
| SG10201908839QA (en) | 2,4-dihydroxy-nicotinamides as apj agonists | |
| HK1248069A1 (zh) | 去乙酰氧基微管溶素h及其类似物 | |
| EA201692525A1 (ru) | Замещенные соединения [1,2,4]триазола и имидазола в качестве фунгицидов | |
| EA033460B1 (ru) | Замещенные [1,2,4]триазольные соединения в качестве фунгицидов | |
| MX2018000515A (es) | Compuestos fluorados de cbd, composiciones y usos de los mismos. | |
| MX2019005855A (es) | Formulaciones que se pueden pulverizar. | |
| MY180844A (en) | Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions | |
| HK1254231A1 (zh) | 米托-和厚朴酚化合物及其合成方法和用途 | |
| TN2016000177A1 (en) | P-substituted asymmetric ureas and medical uses thereof | |
| EP3288636A4 (en) | COMPOSITIONS FOR THE TREATMENT OF EPISTAXIS | |
| HK1255221A1 (zh) | 使用卡多曲组合物进行治疗的方法 | |
| MX2017007380A (es) | Compuestos organicos. | |
| WO2015111004A3 (en) | Improved process for the preparation of chlorophenyl trifluoroethanone | |
| PH12017501869A1 (en) | (s)-2'-vinyl-abscisic acid derivatives | |
| PH12016502592A1 (en) | 3'-substituted-abscisic acid derivatives | |
| WO2016086022A3 (en) | Heteroaromatic imidazolyl compounds and methods for treating cancer |